Matches in SemOpenAlex for { <https://semopenalex.org/work/W2260345492> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2260345492 abstract "Background and Purpose: We showed previously that thrombin enters brain and causes damage to the neurovascular unit (NVU) during ischemia. We hypothesized that the direct thrombin inhibitor argatroban after MCAo would ameliorate behavioral deficits. We explored the therapeutic time window with a standard bioassay following pre-clinical testing guidelines from RIGOR and STAIR. Methods: Male Sprague-Dawley rats underwent MCAo during which each received placebo, 18mg/kg Argatroban over 24 hours (hi dose), or 10mg/kg over 24 hours (lo dose). Blood flow was restored by removing the filament after variable times. At reflow and daily thereafter animals were rated using a modified Bederson scale. After 48 hours the animals were sacrificed and lesion volume measured with TTC imaging (planimetry; Image Pro Plus). Animals were assigned to treatment randomly and studies were triple blinded at surgery, at behavioral assessment, and during histology. We used the quantal bioassay (Exp Neurol 1997;147:346-352) to compute the ED 50 for each group, which measures the duration of ischemia in minutes needed to cause abnormal behavior in 50% of the group. Results: Both doses of argatroban were superior to saline when treatment was delayed as long as 3 hours. For example, after 1 hour delay, the ED 50 ±SD for placebo (n=19) was 24.0±5.6, lo dose (n=19) 46.3±3.4, hi dose (n=19) 40.6±5.7 (p<0.05, t-test, Bonferroni). After 3 hours (Figure), placebo (n=25) was 15.5±3.3, lo dose (n=20) 30.1±5.6, and hi dose (n=20) 30.1±3.74 (P<0.05). After 4 hours delay, there were no beneficial effects. Lesion volumes measured by TTC confirmed the behavioral results. Conclusion: Argatroban after MCAo significantly ameliorated behavioral deficits and reduced lesion volume compared to saline. The effect was robust and seen with 2 doses. Protection was noted after a delay as long as 3 hours but not 4 hours. These data support earlier findings that thrombin inhibition shows promise for neuroprotection." @default.
- W2260345492 created "2016-06-24" @default.
- W2260345492 creator A5018778875 @default.
- W2260345492 creator A5031530997 @default.
- W2260345492 creator A5067092728 @default.
- W2260345492 creator A5073071697 @default.
- W2260345492 creator A5086474167 @default.
- W2260345492 date "2014-02-01" @default.
- W2260345492 modified "2023-09-24" @default.
- W2260345492 title "Abstract W MP73: Protective Effect of Argatroban on Behavioral Outcome Following MCAo up to Four Hours" @default.
- W2260345492 doi "https://doi.org/10.1161/str.45.suppl_1.wmp73" @default.
- W2260345492 hasPublicationYear "2014" @default.
- W2260345492 type Work @default.
- W2260345492 sameAs 2260345492 @default.
- W2260345492 citedByCount "0" @default.
- W2260345492 crossrefType "journal-article" @default.
- W2260345492 hasAuthorship W2260345492A5018778875 @default.
- W2260345492 hasAuthorship W2260345492A5031530997 @default.
- W2260345492 hasAuthorship W2260345492A5067092728 @default.
- W2260345492 hasAuthorship W2260345492A5073071697 @default.
- W2260345492 hasAuthorship W2260345492A5086474167 @default.
- W2260345492 hasConcept C105572291 @default.
- W2260345492 hasConcept C126322002 @default.
- W2260345492 hasConcept C141071460 @default.
- W2260345492 hasConcept C142724271 @default.
- W2260345492 hasConcept C204787440 @default.
- W2260345492 hasConcept C27081682 @default.
- W2260345492 hasConcept C2777292125 @default.
- W2260345492 hasConcept C2779612170 @default.
- W2260345492 hasConcept C42219234 @default.
- W2260345492 hasConcept C541997718 @default.
- W2260345492 hasConcept C71924100 @default.
- W2260345492 hasConcept C89560881 @default.
- W2260345492 hasConceptScore W2260345492C105572291 @default.
- W2260345492 hasConceptScore W2260345492C126322002 @default.
- W2260345492 hasConceptScore W2260345492C141071460 @default.
- W2260345492 hasConceptScore W2260345492C142724271 @default.
- W2260345492 hasConceptScore W2260345492C204787440 @default.
- W2260345492 hasConceptScore W2260345492C27081682 @default.
- W2260345492 hasConceptScore W2260345492C2777292125 @default.
- W2260345492 hasConceptScore W2260345492C2779612170 @default.
- W2260345492 hasConceptScore W2260345492C42219234 @default.
- W2260345492 hasConceptScore W2260345492C541997718 @default.
- W2260345492 hasConceptScore W2260345492C71924100 @default.
- W2260345492 hasConceptScore W2260345492C89560881 @default.
- W2260345492 hasIssue "suppl_1" @default.
- W2260345492 hasLocation W22603454921 @default.
- W2260345492 hasOpenAccess W2260345492 @default.
- W2260345492 hasPrimaryLocation W22603454921 @default.
- W2260345492 hasRelatedWork W10063089 @default.
- W2260345492 hasRelatedWork W1514824226 @default.
- W2260345492 hasRelatedWork W2084885101 @default.
- W2260345492 hasRelatedWork W2231665734 @default.
- W2260345492 hasRelatedWork W2258155351 @default.
- W2260345492 hasRelatedWork W2341988156 @default.
- W2260345492 hasRelatedWork W2351709413 @default.
- W2260345492 hasRelatedWork W2352743481 @default.
- W2260345492 hasRelatedWork W2356494835 @default.
- W2260345492 hasRelatedWork W2364452170 @default.
- W2260345492 hasRelatedWork W2366731768 @default.
- W2260345492 hasRelatedWork W2367107169 @default.
- W2260345492 hasRelatedWork W2371039423 @default.
- W2260345492 hasRelatedWork W2375793089 @default.
- W2260345492 hasRelatedWork W2382866833 @default.
- W2260345492 hasRelatedWork W2391992713 @default.
- W2260345492 hasRelatedWork W2755646611 @default.
- W2260345492 hasRelatedWork W2790081018 @default.
- W2260345492 hasRelatedWork W2883776647 @default.
- W2260345492 hasRelatedWork W3150300412 @default.
- W2260345492 hasVolume "45" @default.
- W2260345492 isParatext "false" @default.
- W2260345492 isRetracted "false" @default.
- W2260345492 magId "2260345492" @default.
- W2260345492 workType "article" @default.